These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21248482)

  • 1. CXCR4 and renal cancer: from lab to bedside.
    Schips L; Volpe A
    Cell Cycle; 2010 Dec; 9(24):4785. PubMed ID: 21248482
    [No Abstract]   [Full Text] [Related]  

  • 2. From molecular understanding to clinical advances.
    Lee CH; Motzer RJ
    Nat Rev Urol; 2014 Feb; 11(2):77-9. PubMed ID: 24366347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL.
    Staller P; Sulitkova J; Lisztwan J; Moch H; Oakeley EJ; Krek W
    Nature; 2003 Sep; 425(6955):307-11. PubMed ID: 13679920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
    Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL
    Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.
    Pan J; Mestas J; Burdick MD; Phillips RJ; Thomas GV; Reckamp K; Belperio JA; Strieter RM
    Mol Cancer; 2006 Nov; 5():56. PubMed ID: 17083723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor suppressor gene VHL, hypoxia inducible factor, and renal cell carcinoma].
    Zhang YT; Chen N; Zeng H; Zhou Q
    Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):562-4. PubMed ID: 17134554
    [No Abstract]   [Full Text] [Related]  

  • 7. pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinoma.
    Struckmann K; Mertz K; Steu S; Storz M; Staller P; Krek W; Schraml P; Moch H
    J Pathol; 2008 Mar; 214(4):464-71. PubMed ID: 18189328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von hippel-lindau: a tumor suppressor links microtubules to ciliogenesis and cancer development.
    Kuehn EW; Walz G; Benzing T
    Cancer Res; 2007 May; 67(10):4537-40. PubMed ID: 17510376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
    Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
    Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
    Schanza LM; Seles M; Stotz M; Fosselteder J; Hutterer GC; Pichler M; Stiegelbauer V
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors in renal cell carcinoma].
    Wen JJ; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):850-3. PubMed ID: 24507112
    [No Abstract]   [Full Text] [Related]  

  • 12. The von Hippel-Lindau gene, kidney cancer, and oxygen sensing.
    Kaelin WG
    J Am Soc Nephrol; 2003 Nov; 14(11):2703-11. PubMed ID: 14569079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From genes to metabolomics in renal cell carcinoma translational research.
    Mulders PF
    Eur Urol; 2013 Feb; 63(2):252-3. PubMed ID: 23182551
    [No Abstract]   [Full Text] [Related]  

  • 14. Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolism.
    Leisz S; Schulz K; Erb S; Oefner P; Dettmer K; Mougiakakos D; Wang E; Marincola FM; Stehle F; Seliger B
    Oncotarget; 2015 May; 6(13):11395-406. PubMed ID: 25890500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressors APC and VHL: gatekeepers of the intestine and kidney.
    Giles RH; Voest EE
    Prog Mol Subcell Biol; 2005; 40():151-81. PubMed ID: 17153484
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunohistochemical detection of the von Hippel-Lindau gene product (pVHL) in human tissues and tumors: a useful marker for metastatic renal cell carcinoma and clear cell carcinoma of the ovary and uterus.
    Lin F; Shi J; Liu H; Zhang J; Zhang PL; Wang HL; Yang XJ; Schuerch C
    Am J Clin Pathol; 2008 Apr; 129(4):592-605. PubMed ID: 18343787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic loss analysis of tumor suppressor genes regardless of heterozygosity: von Hippel-Lindau gene loss in renal cell carcinoma.
    Mochida J; Esumi M; Kitajima A; Okada K
    J Urol; 2008 Aug; 180(2):724-8. PubMed ID: 18554638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness.
    He X; Wang J; Messing EM; Wu G
    Oncogene; 2011 Feb; 30(5):535-47. PubMed ID: 20871634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease.
    Montani M; Heinimann K; von Teichman A; Rudolph T; Perren A; Moch H
    Am J Surg Pathol; 2010 Jun; 34(6):806-15. PubMed ID: 20431476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant versions of von Hippel-Lindau (VHL) can protect HIF1α from SART1-mediated degradation in clear-cell renal cell carcinoma.
    Ordóñez-Navadijo Á; Fuertes-Yebra E; Acosta-Iborra B; Balsa E; Elorza A; Aragonés J; Landazuri MO
    Oncogene; 2016 Feb; 35(5):587-94. PubMed ID: 25915846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.